肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病

2019-07-25 Allan MedSci原创

孤儿药物认定KO-539急性髓细胞白血病
关注

Kura Oncology是一家临床阶段的生物制药公司，专注于开发用于治疗肿瘤的精准药物，近日宣布美国食品和药品监督管理局（FDA）已授予Menin-MLL抑制剂KO-539孤儿药物认定，用于治疗急性髓性白血病（AML）。

Kura Oncology是一家临床阶段的生物制药公司，专注于开发用于治疗肿瘤的精准药物，近日宣布美国食品和药品监督管理局（FDA）已授予Menin-MLL抑制剂KO-539孤儿药物认定，用于治疗急性髓性白血病（AML）。

Kura Oncology总裁兼首席执行官Troy Wilson博士说：“AML的孤儿药物指定代表了KO-539发展的一个重要里程碑。FDA并认识到KO-539有可能解决AML患者的高度未满足的医疗需求。我们的临床前数据也是令人鼓舞的”。


原始出处：

http://www.firstwordpharma.com/node/1654850#axzz5ug3cIKrI

本文系梅斯医学（MedSci）原创编译整理，转载需授权!

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2022-04-26 病毒猎手

    #急性髓细胞白血病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2020-01-10 s_pl2008

    #KO-539#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2019-10-22 ms6980045490879608

    #孤儿药物#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2020-03-02 tastas

    #menin#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2019-12-22 jklm09

    #抑制剂#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2019-08-14 shenxlcyp

    #髓细胞白血病#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2019-07-27 chengjn

    #髓细胞#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1214584, encodeId=f28312145848a, content=<a href='/topic/show?id=fffb52488ef' target=_blank style='color:#2F92EE;'>#急性髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52488, encryptionId=fffb52488ef, topicName=急性髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:22:13 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062745, encodeId=63e92062e455b, content=<a href='/topic/show?id=b6f91055060' target=_blank style='color:#2F92EE;'>#KO-539#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10550, encryptionId=b6f91055060, topicName=KO-539)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71f1477, createdName=s_pl2008, createdTime=Fri Jan 10 00:16:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Tue Oct 22 00:16:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943867, encodeId=023f194386ed4, content=<a href='/topic/show?id=9bb3115483b' target=_blank style='color:#2F92EE;'>#menin#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11548, encryptionId=9bb3115483b, topicName=menin)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Mar 02 00:16:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1852065, encodeId=629c1852065d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sun Dec 22 00:16:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102130, encryptionId=b8611021308a, topicName=髓细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Aug 14 14:16:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468205, encodeId=4ea8146820516, content=<a href='/topic/show?id=71c810212946' target=_blank style='color:#2F92EE;'>#髓细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102129, encryptionId=71c810212946, topicName=髓细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69e46898758, createdName=chengjn, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45433, encryptionId=519345433ea, topicName=孤儿药物认定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cfd19711155, createdName=若水129, createdTime=Sat Jul 27 08:16:00 CST 2019, time=2019-07-27, status=1, ipAttribution=)]
    2019-07-27 若水129

    #孤儿药物认定#

    0

相关资讯

欧盟对Trovagene的PCM-075孤儿药物认定持积极意见

Trovagene制药是一家专业肿瘤治疗公司，正开发用于治疗白血病/淋巴瘤和实体瘤癌症的靶向疗法，Trovagene制药近日宣布欧洲药品管理局（EMA）孤儿药品委员会（COMP）已对PCM-075采纳积极意见，建议将PCM-075指定为治疗急性髓性白血病（AML）的孤儿药

PledPharma在美国为Aladote申请孤儿药物认定

PledPharma制药近日宣布，该公司已就Aladote向美国FDA申请孤儿药物认定（ODD），旨在减少由对乙酰氨基酚（扑热息痛）过量引起的肝损伤。

FDA授予CNP孤儿药物认定用以治疗软骨发育不全

Ascendis是一家生物制药公司，利用其创新的TransCon™技术解决未满足的医疗需求，Ascendis今天宣布美国食品和药品监督管理局（FDA）已授予C型利钠肽（CNP）孤儿药物认定用于治疗软骨发育不全的儿童。

APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病

Apellis是一家临床阶段的生物制药公司，专注于通过抑制补体系统开发治疗疾病的新型疗法，近日宣布其C3补体抑制剂APL-2已被FDA授予孤儿药物认定用于治疗C3肾小球病。

囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定

Synspira Therapeutics近日宣布，欧洲药品管理局（EMA）孤儿药品委员会（COMP）已授予该公司的SNSP113以孤儿药物认定。